WO2024047188 - EXTRAEMBRYONIC MESODERM CELLS
National phase entry is expected:
Publication Number
WO/2024/047188
Publication Date
07.03.2024
International Application No.
PCT/EP2023/073949
International Filing Date
31.08.2023
Title **
[English]
EXTRAEMBRYONIC MESODERM CELLS
[French]
CELLULES DE MÉSODERME EXTRA-EMBRYONNAIRES
Applicants **
KATHOLIEKE UNIVERSITEIT LEUVEN
KU Leuven Research & Development Waaistraat 6 - Box 5105
3000 Leuven, BE
Inventors
PASQUE, Vincent
Elfnovemberlaan 88
3010 Kessel-Lo, BE
PHAM, Thi Xuan Ai
Engels Plein 14 (T.05.18]
3000 Leuven, BE
PANDA, Amitesh
Tweekleinewegenstaat 85 Box 16
3001 Heverlee, BE
BALATON, Bradley
Tervuursestraat 42a 6
3000 Leuven, BE
Priority Data
22193280.9
31.08.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1393 | |
| EPO | Filing, Examination | 6573 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 9310 |
Total: 18440 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention relates to methods wherein extraembryonic mesodermal cells (EXCM) are isolated from cell cultures comprising trophoblast stem cells (TSC), by isolating CHD-1 negative EXCM cells from CHD-1 positive TSC.[French]
L'invention concerne des procédés dans lesquels des cellules de mésoderme extra-embryonnaires (EXCM) sont isolées à partir de cultures cellulaires comprenant des cellules souches trophoblastiques (TSC), par isolement de cellules EXCM négatives CHD-1 à partir de TSC positif CHD-1.